【レポートの概要（一部）】
Table of Contents
Chapter 1. Methodology and Scope
1.1. Information Procurement
1.1.1. Purchased database:
1.1.2. GVR’s internal database
1.2. Research Methodology
1.3. Geographic Scope & Assumptions
1.4. Region-wise Market Calculation
1.4.1. Region-wise market: Base estimates
1.4.2. Global market: CAGR calculation
1.5. Region-based Segment Share Calculation
1.6. List of Secondary Sources
Chapter 2. Executive Summary
2.1. Market Snapshot
Chapter 3. Cancer Biomarkers Industry Outlook
3.1. Market Segmentation & Scope
3.1.1. Market driver analysis
3.1.1.1 Growing geriatric population base
3.1.1.2 Growing prevalence of cancer
3.1.1.3 Increasing government funding for cancer research
3.1.1.4 Technological advancements
3.1.2. Market restraint analysis
3.1.2.1 Large capital investments and production cost
3.2. Penetration & Growth Prospect Mapping
3.3. Cancer biomarkers – SWOT Analysis, By Factor (political & legal, economic and technological)
3.4. Industry Analysis – Porter’s
Chapter 4. Cancer Biomarkers Market: Type Outlook
4.1. Cancer biomarkers market share by type, movement analysis
4.2. Breast cancer
4.2.1. Breast cancer Market estimates and forecast, 2014 – 2025 (USD Billion)
4.4. Prostate Cancer
4.4.1. Prostate cancer market estimates and forecast, 2014 – 2025 (USD Billion)
4.5. Colorectal Cancer
4.5.1. Colorectal cancer market estimates and forecast, 2014 – 2025 (USD Billion)
4.6. Cervical Cancer
4.6.1. Cervical cancer market estimates and forecast, 2014 – 2025 (USD Billion)
4.7. Liver Cancer
4.7.1. Liver cancer market estimates and forecast, 2014 – 2025 (USD Billion)
4.8. Lung Cancer
4.8.1. Lung cancer market estimates and forecast, 2014 – 2025 (USD Billion)
4.9. Others
4.9.1. Others market estimates and forecast, 2014 – 2025 (USD Billion)
Chapter 5. Cancer biomarkers Market: Biomolecule Estimates & Trend Analysis
5.1. Cancer Biomarkers Market: Biomolecule Movement Analysis
5.2. Genetic Biomarkers
5.2.1. Genetic biomarkers market estimates and forecast, 2014 – 2025 (USD Billion)
5.3. Epigenetic Biomarkers
5.3.1. Epigenetic biomarkers market estimates and forecast, 2014 – 2025 (USD Billion)
5.4. Metabolic Biomarkers
5.4.1. Metabolic biomarkers market estimates and forecast, 2014 – 2025 (USD Billion)
5.5. Proteomic Biomarkers
5.5.1. Proteomic biomarkers market estimates and forecast, 2014 – 2025 (USD Billion)
5.6. Others
5.6.1. Others market estimates and forecast, 2014 – 2025 (USD Billion)
Chapter 6. Cancer biomarkers Market: Application Estimates & Trend Analysis
6.1. Cancer Biomarkers Market: Application Movement Analysis
6.2. Drug Discovery
6.2.1. Drug discovery market estimates and forecast, 2014 – 2025 (USD Billion)
6.3. Diagnostics
6.3.1. Diagnostics market estimates and forecast, 2014 – 2025 (USD Billion)
6.4. Personalized Medicine
6.4.1. Personalized medicine market estimates and forecast, 2014 – 2025 (USD Billion)
6.5. Others
6.5.1. Others market estimates and forecast, 2014 – 2025 (USD Billion)
Chapter 7. Cancer Biomarkers Market: Regional Outlook
7.1. Cancer biomarkers market share by region, 2015 & 2025 (USD Billion)
7.2. North America
7.2.1. Market estimates and forecast, 2014 – 2025 (USD Billion)
7.2.1.1. Market estimates and forecast by type, 2014 – 2025 (USD Billion)
7.2.1.2. Product market estimates and forecast by biomolecule, 2014 – 2025 (USD Billion)
7.2.1.3. Market estimates and forecast by application, 2014 – 2025 (USD Billion)
7.2.2. U.S.
7.2.2.1. Market estimates and forecast, 2014 – 2025 (USD Billion)
7.2.2.2. Market estimates and forecast by type, 2014 – 2025 (USD Billion)
7.2.2.3. Product market estimates and forecast by biomolecule, 2014 – 2025 (USD Billion)
7.2.2.4. Market estimates and forecast by application, 2014 – 2025 (USD Billion)
7.2.3. Canada
7.2.3.1. Market estimates and forecast, 2014 – 2025 (USD Billion)
7.2.3.2. Market estimates and forecast by type, 2014 – 2025 (USD Billion)
7.2.3.3. Product market estimates and forecast by biomolecule, 2014 – 2025 (USD Billion)
7.2.3.4. Market estimates and forecast by application, 2014 – 2025 (USD Billion)
7.3. Europe
7.3.1. Market estimates and forecast, 2014 – 2025 (USD Billion)
7.3.1.1. Market estimates and forecast by type, 2014 – 2025 (USD Billion)
7.3.1.2. Product market estimates and forecast by biomolecule, 2014 – 2025 (USD Billion)
7.3.1.3. Market estimates and forecast by application, 2014 – 2025 (USD Billion)
7.3.2. Germany
7.3.2.1. Market estimates and forecast, 2014 – 2025 (USD Billion)
7.3.2.2. Market estimates and forecast by type, 2014 – 2025 (USD Billion)
7.3.2.3. Product market estimates and forecast by biomolecule, 2014 – 2025 (USD Billion)
7.3.2.4. Market estimates and forecast by application, 2014 – 2025 (USD Billion)
7.3.3. UK
7.3.3.1. Market estimates and forecast, 2014 – 2025 (USD Billion)
7.3.3.2. Market estimates and forecast by type, 2014 – 2025 (USD Billion)
7.3.3.3. Product market estimates and forecast by biomolecule, 2014 – 2025 (USD Billion)
7.3.3.4. Market estimates and forecast by application, 2014 – 2025 (USD Billion)
7.4. Asia Pacific
7.4.1. Market estimates and forecast, 2014 – 2025 (USD Billion)
7.4.1.1. Market estimates and forecast by type, 2014 – 2025 (USD Billion)
7.4.1.2. Product market estimates and forecast by biomolecule, 2014 – 2025 (USD Billion)
7.4.1.3. Market estimates and forecast by application, 2014 – 2025 (USD Billion)
7.4.2. China
7.4.2.1. Market estimates and forecast, 2014 – 2025 (USD Billion)
7.4.2.2. Market estimates and forecast by type, 2014 – 2025 (USD Billion)
7.4.2.3. Product market estimates and forecast by biomolecule, 2014 – 2025 (USD Billion)
7.4.2.4. Market estimates and forecast by application, 2014 – 2025 (USD Billion)
7.4.3. India
7.4.3.1. Market estimates and forecast, 2014 – 2025 (USD Billion)
7.4.3.2. Market estimates and forecast by type, 2014 – 2025 (USD Billion)
7.4.3.3. Product market estimates and forecast by biomolecule, 2014 – 2025 (USD Billion)
7.4.3.4. Market estimates and forecast by application, 2014 – 2025 (USD Billion)
7.4.4. Japan
7.4.4.1. Market estimates and forecast, 2014 – 2025 (USD Billion)
7.4.4.2. Market estimates and forecast by type, 2014 – 2025 (USD Billion)
7.4.4.3. Product market estimates and forecast by biomolecule, 2014 – 2025 (USD Billion)
7.4.4.4. Market estimates and forecast by application, 2014 – 2025 (USD Billion)
7.5. Latin America
7.5.1. Market estimates and forecast, 2014 – 2025 (USD Billion)
7.5.1.1. Market estimates and forecast by type, 2014 – 2025 (USD Billion)
7.5.1.2. Product market estimates and forecast by biomolecule, 2014 – 2025 (USD Billion)
7.5.1.3. Market estimates and forecast by application, 2014 – 2025 (USD Billion)
7.5.2. Brazil
7.5.2.1. Market estimates and forecast, 2014 – 2025 (USD Billion)
7.5.2.2. Market estimates and forecast by type, 2014 – 2025 (USD Billion)
7.5.2.3. Product market estimates and forecast by biomolecule, 2014 – 2025 (USD Billion)
7.5.2.4. Market estimates and forecast by application, 2014 – 2025 (USD Billion)
7.5.3. Mexico
7.5.3.1. Market estimates and forecast, 2014 – 2025 (USD Billion)
7.5.3.2. Market estimates and forecast by type, 2014 – 2025 (USD Billion)
7.5.3.3. Product market estimates and forecast by biomolecule, 2014 – 2025 (USD Billion)
7.5.3.4. Market estimates and forecast by application, 2014 – 2025 (USD Billion)
7.6. Middle East & Africa
7.6.1. Market estimates and forecast, 2014 – 2025 (USD Billion)
7.6.1.1. Market estimates and forecast by type, 2014 – 2025 (USD Billion)
7.6.1.2. Product market estimates and forecast by biomolecule, 2014 – 2025 (USD Billion)
7.6.1.3. Market estimates and forecast by application, 2014 – 2025 (USD Billion)
7.6.2. South Africa
7.6.2.1. Market estimates and forecast, 2014 – 2025 (USD Billion)
7.6.2.2. Market estimates and forecast by type, 2014 – 2025 (USD Billion)
7.6.2.3. Product market estimates and forecast by biomolecule, 2014 – 2025 (USD Billion)
7.6.2.4. Market estimates and forecast by application, 2014 – 2025 (USD Billion)
Chapter 8. Company Profiles
8.1. Strategy Framework
8.2. Market Participation Categorization
8.3. Company Profiles
8.3.1. Abbott Laboratories
8.3.1.1. Company overview
8.3.1.2. Financial performance
8.3.1.3. Product benchmarking
8.3.1.4. Strategic initiatives
8.3.2. 9F. Hoffmann-La Roche Ltd
8.3.2.1. Company overview
8.3.2.2. Financial performance
8.3.2.3. Product benchmarking
8.3.2.4. Strategic initiatives
8.3.3. Qiagen N.V
8.3.3.1. Company overview
8.3.3.2. Financial performance
8.3.3.3. Product benchmarking
8.3.3.4. Strategic initiatives
8.3.4. Affymetrix Inc
8.3.4.1. Company overview
8.3.4.2. Financial performance
8.3.4.3. Product benchmarking
8.3.4.4. Strategic initiatives
8.3.5. Illumina, Inc
8.3.5.1. Company overview
8.3.5.2. Financial performance
8.3.5.3. Product benchmarking
8.3.5.4. Strategic initiatives
8.3.6. Agilent Technologies
8.3.6.1. Company overview
8.3.6.2. Financial overview
8.3.6.3. Product benchmarking
8.3.6.4. Strategic initiatives
8.3.7. Merck & Co. Inc
8.3.7.1. Company overview
8.3.7.2. Financial overview
8.3.7.3. Product benchmarking
8.3.7.4. Strategic initiatives
8.3.8. Hologic, Inc.
8.3.8.1. Company overview
8.3.8.2. Financial overview
8.3.8.3. Product benchmarking
8.3.8.4. Strategic initiatives
8.3.9. Sino Biological Inc.
8.3.9.1. Company overview
8.3.9.2. Financial overview
8.3.9.3. Product benchmarking
8.3.9.4. Strategic initiatives
8.3.10. Thermo Fisher Scientific Inc.
8.3.10.1. Company overview
8.3.10.2. Financial overview
8.3.10.3. Product benchmarking
8.3.10.4. Strategic initiatives
8.3.11. Becton, Dickinson and Company
8.3.11.1. Company overview
8.3.11.2. Financial overview
8.3.11.3. Product benchmarking
8.3.11.4. Strategic initiatives
【レポート販売概要】
■ タイトル：がんバイオマーカーの世界市場分析：タイプ別（乳房、前立腺、結腸直腸、子宮頸、肝臓、肺）、生体分子別（遺伝的、後天的、代謝、プロテオーム）、用途別、セグメント予測、2014 – 2025■ 英文：Cancer Biomarker Market Analysis By Type (Breast, Prostate, Colorectal, Cervical, Liver, Lung Cancer), By Biomolecule (Genetic, Epigenetic, Metabolic, Proteomic), By Application, And Segment Forecasts, 2014-2025
■ 発行日：2017年5月29日
■ 調査会社：Grand View Research
■ 商品コード：GVIEW707152
■ 調査対象地域：グローバル
- 子供用バイク及びライド・オンの世界市場2016-2020About the Baby and Children Bikes and Ride On Market Bikes and ride-on products are helpful for children as they help strengthen their leg muscles, improve co-ordination, and encourage babies and children to be active. The improved standards of living, along with rise in disposable income among the middle class population is propelling the demand of baby and children bikes and ride-on in the emerg …
- オゾン発生装置の世界市場2015-2019About Ozone Generation Technology Ozone generation is majorly is used for disinfecting water, equipment and sanitising air. It is also used for bio-waste treatment and therapy of diseases such as cancer and AIDS. Ozone may be produced using traditional methods such as corona discharge, UV light and recently by electrolytic method which provides higher purity and concentration. The most common type …
- 事業提携・ライセンシング・投資・M&A動向：February 2013（製薬業界）Partnerships, Licensing, Investments and M&A Deals and Trends for February 2013 in Pharmaceuticals Summary GlobalData's “Partnerships, Licensing, Investments and M&A Deals and Trends for February 2013 in Pharmaceuticals” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The report pro …
- 調理器具の世界市場2019-2023105 Pages, November 2018 About this market Over the years, the demand for multi-cooktop compatible cookware has been rising, thanks to the growing popularity of induction cook-tops worldwide. Copper is a preferred cookware material owing to its even heat distribution properties. Although copper cookware continues to be a niche market in 2018, several copper cookware vendors are providing a range o …
- PharmaFocus: Vaccine Adjuvants in Infectious DiseasePharmaFocus: Vaccine Adjuvants in Infectious Disease Summary Originally discovered by Glenny in the 1920s, vaccine adjuvants have remained the pharmaceutical industry’s “dirty little secret”. Today, vaccine adjuvants are credited with helping to bolster the immune response in the host post-vaccination. Recently, second-generation adjuvants have come under scrutiny after reports that the adjuvant u …
- E.ON SE：石油・ガスバリューチェーン分析レポート2013E.ON SE Analysis Across the Oil and Gas Value Chain Report, 2013 Update Summary "E.ON SE" Analysis Across the Oil and Gas Value Chain is an essential source for data, analysis and strategic insight into “E.ON SE”. The report provides key information relating to oil and gas assets of the company along with its operations across the value chain. The report examines the company’s business structure, …
- バイオ燃料添加剤の世界市場2015-2022According to Stratistics MRC, the Global Biofuel Additives Market is accounted for $4,424 million in 2015 and is expected to reach $12,340 million by 2022 growing at a CAGR of 15.8% during the forecast period. Increasing biofuel usage owing to decreasing reliance on the oil producing countries and supportive government regulations are the key factors fueling the market growth. High cost of these a …
- 強化ガラスの世界市場分析：用途別（自動車、建設）、セグメント予測Global tempered glass market is expected to reach USD 54.31 billion by 2022, according to a new report by Grand View Research, Inc. Growing automobile demand on account of rising disposable income is expected to be the major driver for tempered glass market growth. Transition in building architecture which includes maximizing natural light through use of glass in facades and roofs is further expec …
- 世界の再生可能エネルギー技術への投資動向：Investment in Renewable Technologies WorldwideRenewable energy is responsible for contributing almost 29.3% of human energy use all across the globe. With pollution levels rising incessantly, renewable energy resources have turned out to be a major boon to the environment as well as investors world over. Green energy overtook fossil fuels in attracting investment for power generation in the recent times. Wind, solar and other clean technologi …
- Salamander Energy plc：石油・ガスの開発・生産動向及びコスト分析– 2012Salamander Energy plc Oil & Gas Exploration and Production Operations and Cost Analysis – 2012 Summary Salamander Energy plc Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source for …
- 世界の予測分析市場（不正行為、詐欺、リスク、マーケティング、オペレーション）The surging competition across various industry verticals need to look out for newer technologies to maintain their foothold in the ever-changing market. Regardless of the industry type and organizational size, big data is generated with every instance of consumer interaction. Predictive analytics ensures that this big data is scrutinized and correlated with present and past historical trends, to …
- ソーラーコントロールガラスの世界市場分析：用途別（住宅用建物、商業ビル、自動車）、セグメント予測The global solar control glass market is expected to reach USD 8.88 billion by 2024, according to a new report by Grand View Research, Inc. Increasing demand owing to positive construction and automotive industry outlook is expected to propel solar control glass market growth. Solar control glass allows a significant amount of sunlight to pass through and reflects a large amount of solar heat thus …
- マイクロ流体のグローバル市場動向The healthcare segment is featured with microfluidic applications which refers to the flow of biological liquids through micro channels ranging from nanolitres to few picoltres. This newest approach adds several benefits to the medical world, such as large surface to volume ratio, less reagent consumption, quick diagnosis and high accuracy of the results. Thus, the emerging field of ‘microfluidics …
- ガス絶縁開閉器の世界市場予測（～2021）：種類別（高圧＆中圧）、サブタイプ別、需要先別、地域別The global gas insulated switchgear market is projected to grow at a CAGR of 9.4% from 2016 to 2021, to reach a market size of USD 25.95 Billion by 2021. This growth is attributed to efficiency and reliability of gas insulated switchgear, with less space constraints and low maintenance. The report segments gas insulated switchgear market on the basis of major end-users, which include transmission …
- 薄膜太陽電池に関する市場分析：Thin Film Solar CellsThe Sun, believed by the mankind to be just a mere centerpiece of the solar system in which we live is in reality not just a unit but an entire symphonic system which was in place much before the first humans ever walked on planet earth. This system which has been the primary energy source for origin of life on earth is in fact very well adequately positioned by nature to fulfill the needs of ener …
